Fresenius Medical Care AG & Co. KGaA (FME) PT Set at €84.20 by JPMorgan Chase & Co.

JPMorgan Chase & Co. set a €84.20 ($97.91) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research report released on Wednesday. The firm currently has a buy rating on the stock.

Other research analysts also recently issued reports about the company. Goldman Sachs Group set a €98.00 ($113.95) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Monday, October 1st. UBS Group set a €86.00 ($100.00) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Wednesday, October 17th. Commerzbank set a €82.00 ($95.35) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Tuesday, July 31st. Barclays set a €86.00 ($100.00) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Monday, July 16th. Finally, Oddo Bhf set a €96.00 ($111.63) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Wednesday, August 1st. Eight equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Fresenius Medical Care AG & Co. KGaA currently has an average rating of Buy and a consensus target price of €90.14 ($104.82).

ETR:FME opened at €70.82 ($82.35) on Wednesday. Fresenius Medical Care AG & Co. KGaA has a 52-week low of €75.53 ($87.83) and a 52-week high of €93.82 ($109.09).

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

See Also: What are the components of an earnings report?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply